trending Market Intelligence /marketintelligence/en/news-insights/trending/ck_sxzozgnl9obceuzbz7q2 content esgSubNav
In This List

Scythian Biosciences extends letter of intent to buy medical cannabis company

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Scythian Biosciences extends letter of intent to buy medical cannabis company

Scythian Biosciences Corp. said it extended the previously announced letter of intent to buy MMJ International Investments Inc., a company pursuing medical cannabis opportunities in South America.

The companies now have until April 30 to negotiate a definitive deal, as opposed to March 31 previously.

Scythian, a Canadian medical cannabis company, added that its COO David Schrader will step down on March 31.